LeonaBio (LONA) Non Operating Income (2019 - 2026)
LeonaBio (LONA) reported Non Operating Income of $586000.0 for Q1 2026, up 49.11% year-over-year from $393000.0 in Q1 2025, and up 129.8% on a QoQ basis from $255000.0 in Q4 2025.
LeonaBio (LONA) has 8 years of Non Operating Income data on file, last reported at $586000.0 in Q1 2026.
- Quarterly Non Operating Income rose 49.11% year-over-year to $586000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (down 52.45% YoY) and the FY2025 annual result came in at $1.2 million, down 68.8% from the prior year.
- Non Operating Income advanced to $586000.0 in Q1 2026 per LONA's latest filing, from $255000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $2.1 million in Q3 2023 and bottomed at $173000.0 in Q1 2022.
- The 5-year median for Non Operating Income is $880000.0 (2024), against an average of $978647.1.
- The widest annual swing landed in 2022, when Non Operating Income jumped 1419.42%; it then plunged 72.2% in 2025.
- Tracing LONA's Non Operating Income over 5 years: stood at $1.6 million in 2022, then increased by 10.48% to $1.7 million in 2023, then sank by 67.44% to $563000.0 in 2024, then tumbled by 54.71% to $255000.0 in 2025, then soared by 129.8% to $586000.0 in 2026.
- Per Business Quant, the three latest LONA Non Operating Income figures stand at $586000.0 (Q1 2026), $255000.0 (Q4 2025), and $263000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -46.98 Mn |
| 10 | LeonaBio | 181.52 Mn | 113.84 Mn | - | 586,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 586,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Sep 30, 2025 | 263,000.00 |
| Jun 30, 2025 | 325,000.00 |
| Mar 31, 2025 | 393,000.00 |
| Dec 31, 2024 | 563,000.00 |
| Sep 30, 2024 | 880,000.00 |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 2.04 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Sep 30, 2022 | 985,000.00 |
| Jun 30, 2022 | 493,000.00 |
| Mar 31, 2022 | 173,000.00 |
| Dec 31, 2021 | 103,000.00 |
| Sep 30, 2021 | 73,000.00 |
| Jun 30, 2021 | 74,000.00 |
| Mar 31, 2021 | 84,000.00 |
| Dec 31, 2020 | 78,000.00 |
| Sep 30, 2020 | -1.06 Mn |
| Jun 30, 2020 | 260,000.00 |
| Mar 31, 2020 | -560,000.00 |
| Dec 31, 2019 | -611,000.00 |
| Sep 30, 2019 | 5,000.00 |